Ken ChengPresident

• Dongguan Shun Cheng Computer Enteprise Corporation　Director of Board
• Solytech Enteprise Corporation　President
• Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years.

Akaphot Thongmee (Mark), M.D.,Chief Medical Officer

Dr. Mark Thongmee, M.D., MRCP (UK), is a translational research physician trained in Translational Medicine and Early Phase Development from Imperial College London.
With over a decade of experience, he has contributed significantly to clinical trials in infectious diseases and oncology across Southeast Asia, including leading community-based trials for HIV and HCV. He has spearheaded numerous research trials and medical initiatives, notably as;

• Global Medical Affairs lead at GPCRO Contract Research Organisation, leading the clinical trial designed and medical monitor for oncology, ophthalmology, COVID-19 infection, and gene therapy.
• Country Medical Director at Amgen and Allergan, he bridged clinical research with strategic medical affairs, enhanced drug accessibility, and implemented health economic outcomes research (HEOR) to support reimbursement strategies.

Simon HuangGeneral Manager

• NYIT　M.B.A.
• Barits Securities Corporation　Researcher
• Solytech Enteprise Corporation　Independent President
• Taipei Biotech Association　Supervisor
• Professional experiences in clinical trail over 6 years
• Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.

Amy ChenOffice of General Affairs Director& Chief Financial Officer

• Royal Roads University M.B.A. in Executive Management
• Wayi International Digital Entertainment Co.,Ltd..　Manager
• Professional experiences in financial management and fund allocation for over 25 years.